Benacort switched to GSL status in the UK

20 November 2020 - Deborah Wilkes

Premium

Johnson & Johnson’s Benacort Hayfever Relief – containing the intranasal corticosteroid budesonide – has been switched to general-sales list (GSL) status in the UK.

Click tags below for more information on topics:

Johnson & Johnson MHRA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: